Products

Primary tabs

Export products to Excel

Displaying 61 - 75 of 209
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Project Stage: Phase I
Partner: Femsays Inc
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Regulatory
Alternative Name: Fibroplant LNG14 (also LNG 20)
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Regulatory
Development Status: Limited Market Approval
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Marketed
Development Status: Inactive
Target: Male
Mode: Non-hormonal
Delivery Type: Injectable
Project Stage: Pre-clinical
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Pre-clinical
Alternative Name: Sperm glycolytic enzyme
Development Status: Active Development
Target: Female, Male
Mode: Non-hormonal
Delivery Type: TBD
Project Stage: Target ID/Validation
Alternative Name: FC-Patch low, Lisvy®
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Regulatory
Alternative Name: Single Rod GES Implant
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Phase III
Alternative Name: GES IUD
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Lead Optimization
Alternative Name: Gonadotropin releasing hormone (GnRH) II receptor anatagonists
Target: Female
Mode: Non-hormonal
Delivery Type: TBD
Project Stage: Target ID/Validation
Development Status: Inactive
Target: Male
Mode: Non-hormonal
Delivery Type: Oral
Project Stage: Phase I
Alternative Name: SARM C-6
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Oral
Project Stage: Pre-clinical
Export to Excel